- Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines Join our team and explore clinical trials
- Regeneron Pharmaceuticals - Wikipedia
Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc is an American biotechnology company headquartered in Westchester County, New York The company was founded in 1988 [2]
- Investor Relations | Regeneron Pharmaceuticals Inc.
About Regeneron Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases
- Regeneron Pharmaceuticals, Inc. (REGN) Stock Price, News, Quote . . .
Find the latest Regeneron Pharmaceuticals, Inc (REGN) stock quote, history, news and other vital information to help you with your stock trading and investing
- Regeneron declines to make higher bid for 23andMe after Wojcickis $305 . . .
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday
- Regeneron Stock Plunges 22. 6% YTD: Should You Buy, Sell or Hold?
Eylea's sales slump and pipeline setbacks have dragged REGN down 22 8% YTD, underperforming its peers and the S P 500
- Regeneron Pharmaceuticals (REGN) Stock Price Overview
A detailed overview of Regeneron Pharmaceuticals, Inc (REGN) stock, including real-time price, chart, key statistics, news, and more
- About Regeneron | Our Company
We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center ® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases
|